XYNGARI
Live / Applied — Second extension granted (statement of use) (as of 31 Oct 2025)
What this means for you
Not registered yet, but its 15 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98451184
- Mark type
- Stylized text
- Filed
- 15 Mar 2024
- Published for opposition
- 05 Nov 2024
- Attorney of record
- Andrew D. Skale
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of medical and aesthetic skin conditions and diseases; Dermatological pharmaceutical preparations
Owner
- DERMATA THERAPEUTICS, INC., SAN DIEGO, CA, US
- Dermata Therapeutics, LLC, San Diego, CA, US
- Dermata Therapeutics, LLC, San Diego, CA, US
Prosecution history
- 01 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Oct 2025 — SOU EXTENSION 2 GRANTED
- 31 Oct 2025 — SOU EXTENSION 2 FILED
- 31 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 09 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 May 2025 — SOU EXTENSION 1 GRANTED
- 08 May 2025 — SOU EXTENSION 1 FILED
- 08 May 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Feb 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 17 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Nov 2024 — PUBLISHED FOR OPPOSITION
- 16 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Sept 2024 — ASSIGNED TO EXAMINER